Celyad SA (CYAD:NASDAQ) shot up at $1.9, a gain of 137.8%. On Tue, Jan 17, 2023, CYAD:NASDAQ hit a New 2-Week High of $1.9. The stock appeared on our News Catalysts scanner on Wed, Dec 21, 2022 at 01:10 PM in the 'INVESTOR UPDATE' category. From Tue, Jan 03, 2023, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Tue, Jan 17, 2023 at $2.5 with a volume of 65M+.
About Celyad SA (CYAD:NASDAQ)
Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.
Top 10 Gainers:
- Celyad SA (CYAD:NASDAQ), 137.8%
- Calyxt, Inc. (CLXT:NASDAQ), 90.25%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 60.48%
- BIT Mining Limited ADS (BTCM:NYSE), 42.02%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 39.69%
- Aterian Inc. (ATER:NASDAQ), 37.35%
- Digihost Technology Inc. (DGHI:NASDAQ), 32.91%
- OneConnect Financial Technology Co., Ltd. (OCFT:NYSE), 32.22%
- Arcimoto, Inc. (FUV:NASDAQ), 31.33%
- RenovoRx Inc. (RNXT:NASDAQ), 31.23%